Get the Weekly Intelligence Brief — top committee picks every Sunday.

GMAB vs NVST

Genmab A/S vs Envista Holdings — AI-powered side-by-side comparison
GMAB
Genmab A/S
60
Buy
VS
NVST
Envista Holdings
76
Strong Buy
MetricGMABNVST
AI Score 60 76
Price $30.82 $28.51
P/E Ratio 24.04× 48.34×
ROE 16.5% 1.5%
Revenue Growth YoY
Gross Margin 39.9% 55.5%
Debt / Equity 0.89× 0.52×
Dividend Yield 0.0% 0.0%
RSI (14) 72.5 59.3
Beta 0.685 0.861
Expected Upside +1.4%

AI Committee View

Current Innellis committee reasoning for GMAB versus NVST.
NVST leads by 16 points.

NVST scores 76/100 (Strong Buy) versus GMAB at 60/100 (Buy).

GMAB Committee View
60% agreement
5 analysts

Positive signals support the current rating — vix regime is low -- calm backdrop supports risk-taking. The committee sees sufficient evidence to maintain the constructive view.

Bull Case
  • Price structure making higher highs and higher lows — Technical
  • MACD histogram positive -- bullish momentum — Technical
  • Weekly trend (uptrend) confirms the daily trend -- multi-timeframe agreement — Technical
Bear Case
  • EPS declining -25.3% YoY despite any revenue growth — Growth
  • RSI at 73 is in overbought territory — Technical
NVST Committee View
100% agreement
4 analysts

The primary driver is 5 consecutive earnings beats -- consistent execution. The main limiting factor is 2 existing position pair(s) are highly correlated already. The committee is constructive but not yet at full conviction.

Bull Case
  • 5 consecutive earnings beats -- consistent execution — Growth
  • Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
  • Price structure making higher highs and higher lows — Technical
Bear Case
  • Weekly trend is bearish while daily is bullish — against the higher-timeframe trend.
  • Risk/reward is unfavorable: 14.2% downside vs 1.4% upside.
Want the full breakdown?
Committee votes, technicals, and trade plans for both companies.
GMAB Full Analysis NVST Full Analysis